Risk of 30-Day All-Cause Readmission in Interstitial Lung Disease Patients after COVID-19: National-Level Data

Annals of the American Thoracic Society,Volume 21, Issue 3, Page 428-437, March 2024.

https://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.202305-491OC?af=R

Source: Annals of the American Thoracic Society - March 1, 2024 Category: Respiratory Medicine Authors: Ali Vaeli Zadeh Roshan Dinparastisaleh Atefeh Vaezi Debabrata Bandyopadhyay Israel Rubinstein Hassan Z. Baig Rafael Calderon-Candelario Abdolrazagh Hashemi Shahraki Takeshi Kawasaki Jesper M. Magnusson Lars-Olof Larsson Amir Sharafkhaneh Jose D. Herazo-Ma Source Type: research

More News: COVID-19 | Interstitial Lung Disease | Israel Health | Middle East Health | Respiratory Medicine